BioMatrix Stent Better Over Longer Term

TCT 2013 — SAN FRANCISCO — In patients with ST-segment elevation myocardial infarction, the benefits of the biolimus-eluting BioMatrix stent over a bare-metal stent were sustained through 2 years, a randomized trial showed.

Keywords: Transcatheter Cardiovascular Therapeutics


< Back to Listings